An open trial of octreotide long-acting release in the management of short bowel syndrome

American Journal of Gastroenterology

Volumn 96, Issue 5, 2001, Pages 1494-1498

  Nehra, Vandana ^a   Camilleri, Michael ^a   Burton, Duane ^a   Oenning, Lavonne ^a   Kelly, Darlene G ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FECES LIPID; OCTREOTIDE; POTASSIUM; SODIUM;

ADULT; AGED; ARTICLE; BODY WEIGHT; CARCINOID; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DRUG EFFECT; DRUG FORMULATION; ELECTROLYTE EXCRETION; FECES; FECES ANALYSIS; FEMALE; HUMAN; INTESTINE ISCHEMIA; INTESTINE RESECTION; INTESTINE TRANSIT TIME; ISOTOPE LABELING; MALE; MEAL; PRIORITY JOURNAL; SHORT BOWEL SYNDROME; STOMACH EMPTYING; SUSTAINED RELEASE PREPARATION; URINE VOLUME;

EID: 0034997050     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(01)02366-8     Document Type: Article

References (25)

1. Nightingale J.M.D., Lennard-Jones J.E. The short bowel syndrome. What's new and old. Dig Dis. 11:1993;12-31.
2. Lin H.C., Zhao X.T., Wang L. Intestinal transit is more potently inhibited by fat in distal (ileal brake) than in proximal (jejunal brake) gut. Dig Dis Sci. 42:1997;19-25.
3. Cuche G., Malbert C.H. Ileal short-chain fatty acids inhibit transpyloric flow in pigs. Scand J Gastroenterol. 34:1999;149-155.
4. Byrne T.A., Persinger R.L., Young L.S., et al. A new treatment for patients with short bowel syndrome Growth hormone, glutamine and a modified diet . Ann Surg. 222:1995;243-255.
5. Scolapio J.S., Camilleri M., Fleming C.R., et al. Effect of growth hormone, glutamine, and diet on adaptation in short bowel syndrome Randomized, controlled study . Gastroenterology. 113:1997;1077-1081.
6. Grant D. Intestinal transplantation 1997 Report of the international registry . Transplantation. 67:1999;1061-1064.
7. Dowling R.H. Small bowel adaptation and its regulation. Scand J Gastroenterol. 74:1982;53-74.
8. Koruda M.J., Rolandelli R.H., Settle R.G. Effect of parenteral nutrition supplemented with short chain fatty acids on adaptation to massive small bowel resection. Gastroenterology. 95:1988;715-720.
9. Altmann G.G. Influence of bile and pancreatic secretions on the size of intestinal villi in the rat. Am J Anat. 132:1971;167-178.
10. Lembcke B., Creutzfeldt W., Schleser S., et al. Effect of somatostatin analogue sandostatin (SMS 201-995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men. Digestion. 36:1987;108-124.
11. Krejs G.J. Physiological role of somatostatin in the digestive tract Gastric acid secretion, intestinal absorption and motility . Scand J Gastroenterol. 21:1986;43-47.
12. Lucey M.R., Yamada T. Biochemistry and physiology of gastrointestinal somatostatin. Dig Dis Sci. 43:1989;5-13.
13. Ladefoged K., Christensen K.C., Hegnhoj T., Jarnum S. Effect of a long acting somatostatin analogue SMS 201-995 on jejunostomy effluent in patients with severe short bowel syndrome. Gut. 30:1989;943-949.
14. O'Keefe S.J., Peterson M.C., Fleming R.C. Octreotide as an adjunct to home parenteral nutrition in the management of permanent end-jejunostomy syndrome. J Parenteral Enteral Nutr. 18:1994;26-34.
15. Nightingale J.M., Walker E.R., Burnham W.R., et al. Octreotide (a somatostatin analogue) improves the quality of life in some patients with short intestine. Aliment Pharmacol Ther. 3:1989;367-373.
16. Cooper J.C., Williams N.S., King R.F., Barker M.C. Effects of a long-acting somatostatin analogue in patients with severe ileostomy diarrhoea. Br J Surg. 73:1986;128-131.
17. Sandostatin LAR Injection. Investigator's Brochure. Human pharmacokinetic/pharmacodynamic and safety studies. East Hanover, NJ: Sandoz Research Institute, 1995:17-9.
18. Tietz N.W. Textbook of clinical chemistry, 1st ed. 1986;Saunders, Philadelphia.
19. Camilleri M., Zinsmeister A.R., Greydanus M.P., et al. Towards a less costly but accurate test of gastric emptying and small bowel transit. Dig Dis Sci. 36:1992;609-615.
20. O'Donnell L.J.D., Watson A.J.M., Cameron D., Farthing M.J.G. Effects of octreotide on mouth to cecum transit time in healthy subjects and irritable bowel syndrome. Aliment Pharmacol Ther. 4:1990;177-182.
21. von der Ohe M.R., Camilleri M., Thomforde G.M., Klee G.G. Differential regional effects of octreotide on human gastrointestinal motor function. Gut. 36:1995;743-748.
22. Dueno M.I., Bai J.C., Santangelo W.C., Krejs G.J. Effect of somatostatin analog on water and electrolyte transport and transit time in human small bowel. Dig Dis Sci. 32:1987;1092-1096.
23. von der Ohe M., Layer P., Wollny C., et al. Somatostatin-28 and coupling of human interdigestive intestinal motility and pancreatic secretion. Gastroenterology. 103:1992;974-981.
24. Neri M., Cuccurullo F., Marzio L. Effect of somatostatin on gall bladder volume, and small intestinal motor activity in humans. Gastroenterology. 98:1990;316-321.
25. Haruma K., Wiste J.A., Camilleri M. Effect of octreotide on gastrointestinal pressure profiles in health and in functional and organic gastrointestinal disorders. Gut. 35:1994;1064-1069.